Skip to content

Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain

Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05763758
Enrollment
200
Registered
2023-03-10
Start date
2023-11-21
Completion date
2027-01-31
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Experimental Pain, Low Back Pain

Keywords

EEG, fMRI, thalamus, pain, experimental pain, low back pain

Brief summary

This study aims to identify spatiotemporal alterations in thalamocortical circuitry functioning in both healthy subjects and patients with chronic pain, combining multimodal neuroimaging.

Detailed description

Investigators will pursue this goal in both experimental and clinical models at two sites (Florida State U/FSU & Mass General Hospital/MGH), implementing parallel enrollment of large and diverse samples (140 healthy participants and 60 patients with chronic low back pain/cLBP). Leveraging the fully developed multimodal neuroimaging methodology-simultaneous EEG-fMRI and combined EEG-MEG-fMRI, the investigators will investigate TC dysconnectivity (fMRI) and alpha dysrhythmia (EEG/MEG) during experimental pressure pain and chronic back pain.

Interventions

OTHERNo intervention

No intervention involved in this study

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER
Florida State University
CollaboratorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy subjects for both MGH and FSU sites Inclusion Criteria: 1. healthy male and female adults 2. Between the ages of 18 and 60 years 3. Meeting the MRI / MEG / EEG screening criteria 4. Fluent in English; English can be a second language provided that the patients understand all questions used in the assessment measures. This will be asked and judged during the phone screen.

Exclusion criteria

1. Current or past history of major medical, neurological, or psychiatric illness based on self-report 2. History of cardiac, respiratory, or nervous system disease that, in the investigator's judgment, precludes participation in the study because of a heightened potential for adverse outcome (for example: asthma or claustrophobia) 3. History of head trauma 4. Pregnant or lactating 5. Presence of any contraindications to MRI scanning (for example: cardiac pacemaker, metal implants, claustrophobia, pregnancy, cannot lie still in fMRI scanner) 6. Conditions making study participation difficult (e.g., paralysis, psychoses, or other severe psychological problems as per the judgment of a study investigator during Session 1) 7. Active substance abuse disorders (based on subject self-report) Subjects with chronic low back pain (MGH site) Inclusion Criteria: 1. Volunteers 18-60 years of age 2. Meet the Classification Criteria of the chronic LBP (having low back pain for more than 6 months) 3. At least 4/10 clinical pain on the 0-10 LBP NRS 4. Meeting the MRI / MEG / EEG screening criteria 5. Fluent in English; English can be a second language provided that the patients understand all questions used in the assessment measures. This will be asked and judged during the phone screen.

Design outcomes

Primary

MeasureTime frameDescription
thalamocortical functional connectivitybaselinefunctional connectivity between the thalamus and cortex as measured by resting state fMRI
alpha oscillationsbaselinealpha oscillations as measured by EEG and MEG

Secondary

MeasureTime frameDescription
alpha band sourceBaselineMEG and EEG data will be used to estimate the alpha band source

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026